维普中文期刊产品整合服务
24篇 您的检索式:作者名="Chambers SA"
    题名 作者 年代 出处 被引量
1Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies 显示文摘Peggs KS Quezada SA Chambers CA 2009J Exp Med2009,206,8:1
2Diversity of the ribosomal internal transcribed spacers within and among isolates of Glomus mosseae and related mycorrhizal fungi 显示文摘Lloyd MacGilp SA Chambers S Dodd M 1996New Phytologist1996,133,:1
3Isolation and characterisation of symbiotically effective Rhizobium resistant to arsenic and heavy metals after the toxic spill at the Aznalcóllar pyrite mine显示文摘José Antonio Carrasco Patricia Armario Eloísa Pajuelo Araceli Burgos Miguel A. Caviedes Rafael López Manuel A. Chamber Antonio J. Palomares 2004Soil Biology and Biochemistry2004,,6:1
4Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti- CTLA-4 antibodies显示文摘Peggs KS Quezada SA Chambers CA 2009J Exp Med2009,206,8:1
5Why do patients with systemiclupus erythematosus take or fail to take their prescribed medicationsA qualitative study in a UK cohort 显示文摘Chambers SA Raine RRahman A 2009Rheumatology(Oxford)2009,48,3:1
6Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model显示文摘Vantyghem SA Wilson SM Postenka CO A1-Katib W Tuck AB Chambers AF 2005Cancer Res2005,65,8:1
7Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort显示文摘Chambers SA Raine R Rahman A 2009Rheumatology (Oxford)2009,48,3:1
8Blockade of CTLA-4 on both effector and regulatory T cell compart- ments contributes to the antitumor activity of anti-CTLA- 4 antibodies显示文摘Peggs KS Quezada SA Chambers CA 2009J Exp Med2009,206,:1
9Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years显示文摘Chambers SA Allen E Rahman A 2009Rheumatology (Oxford)2009,48,6:1
10Damage and mortality in agroup of British patients with systemic lupus erythematosus followedup for over 10 years显示文摘Chambers SA Allen E Rahman A 2009Rheumatology (Oxford)2009,48,6:1
11Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1 显示文摘Steer SA Scarim AL Chambers KT 2006Plos Med2006,3,2:1
12Knee strength capa- bilities and slip severity 显示文摘Wyszomierski SA Chambers A J Chain R 2009J Appl Biomech2009,25,2:1
13Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years显示文摘Chambers SA Alien E Rahman A 2009Rheumatology2009,48,6:1
14Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort 显示文摘Chambers SA Raine R Rahman A 2009Rheumatology (Oxford)2009,48,3:1
15Interleukin-1 stimulates β-cell necrosis and release of the immunological adjuvant HMGB1显示文摘Steer SA Scarim AL Chambers KT 2006PLoS Med2006,3,2:1
16Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies显示文摘Peggs KS Quezada SA Chambers CA 2009J Exp Med2009,206,8:1
17Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1 显示文摘Steer SA Scarim AL Chambers KT Corbett JA 2005PLoS Med2005,3,2:1
18Knee strength capa-bilities and slipseverity 显示文摘Wyszomierski SA Chambers AJ Cham R 2009J Appl Biomech2009,25,2:1
19High-level generation of polyclonal antibodies by genetic immunization显示文摘Chambers RS Johnston SA 2003Nat Biotechnol2003,21,:1
20High-level generation of polyclonal antibodies by genetic immunization显示文摘CHAMBERS RS JOHNSTON SA 2003Nat Biotechnol JT-Nature biotechnology2003,21,9:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费